Skip to main content
Erschienen in:

06.04.2019

The kallikrein-like activity of Heloderma venom is inhibited by carbon monoxide

verfasst von: Vance G. Nielsen, Nathaniel Frank

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Lizards in the genus Heloderma are the most ancient venomous reptiles, with a traceable lineage nearly 100 million years old. The proteome of the venom of three of the remaining species (Heloderma suspectum, H. exasperatum, H. horridum) are very conserved, with kallikrein-like activity present to cause critical hypotension to immobilize and outright kill prey. Kallikrein-like activity would be expected to activate the contact protein pathway of coagulation, which would be detectable with thrombelastography in human plasma. Thus, it was proposed to determine if kallikrein-like activity could be detected with thrombelastography, and if this activity could be inhibited by carbon monoxide (CO) via a putative heme-based mechanism. Procoagulant activity of each venom was assessed via thrombelastography with normal plasma, and kallikrein-like activity confirmed with FX-depleted plasma. Venom was then exposed to carbon monoxide releasing molecule-2 (CORM-2) or its inactive releasing molecule to assess CO inhibition. All three venoms demonstrated kallikrein-like activity with the same potency and inhibition of activity by CO. In conclusion, the present work documented that procoagulant, kallikrein-like activity containing venoms of the oldest species of venomous reptiles was inhibited by CO, potentially via heme modulation. This is also the first identification and characterization of a kallikrein-like enzyme utilizing coagulation factor-depleted plasma to assess venom that inflicts hypotension. Future investigations will continue to define the vulnerability of venom enzymatic activities to CO.
Literatur
1.
Zurück zum Zitat Beaman KR, Beck DD, McGurty BM (2006) The beaded lizard (Heloderma horridum) and gila monster (Heloderma suspectum): a bibliography of the family Helodermatidae. Smithson Herpetol Inf Serv 136:1–66 Beaman KR, Beck DD, McGurty BM (2006) The beaded lizard (Heloderma horridum) and gila monster (Heloderma suspectum): a bibliography of the family Helodermatidae. Smithson Herpetol Inf Serv 136:1–66
2.
Zurück zum Zitat Fry BG, Vidal N, Norman JA, Vonk FJ, Scheib H, Ramjan SF, Kuruppu S, Fung K, Hedges SB, Richardson MK, Hodgson WC, Ignjatovic V (2006) Early evolution of the venom system in lizards and snakes. Nature 439:584–588CrossRefPubMed Fry BG, Vidal N, Norman JA, Vonk FJ, Scheib H, Ramjan SF, Kuruppu S, Fung K, Hedges SB, Richardson MK, Hodgson WC, Ignjatovic V (2006) Early evolution of the venom system in lizards and snakes. Nature 439:584–588CrossRefPubMed
3.
Zurück zum Zitat Douglas ME, Douglas MR, Schuett GW, Beck DD, Sullivan BK (2010) Conservation phylogenetics of helodermatid lizards using multiple molecular markers and a supertree approach. Mol Phylogenet Evol 55:153–167CrossRefPubMed Douglas ME, Douglas MR, Schuett GW, Beck DD, Sullivan BK (2010) Conservation phylogenetics of helodermatid lizards using multiple molecular markers and a supertree approach. Mol Phylogenet Evol 55:153–167CrossRefPubMed
4.
Zurück zum Zitat Reiserer RS, Schuett GW, Beck DD (2013) Taxonomic reassessment and conservation status of the beaded lizard, Heloderma horridum (Squamata: Helodermatidae). Amphib Reptile Conserv 7:74–96 Reiserer RS, Schuett GW, Beck DD (2013) Taxonomic reassessment and conservation status of the beaded lizard, Heloderma horridum (Squamata: Helodermatidae). Amphib Reptile Conserv 7:74–96
5.
Zurück zum Zitat Koludarov I, Jackson TN, Sunagar K, Nouwens A, Hendrikx I, Fry BG (2014) Fossilized venom: the unusually conserved venom profiles of Heloderma species (beaded lizards and gila monsters). Toxins 6:3582–3595CrossRefPubMedPubMedCentral Koludarov I, Jackson TN, Sunagar K, Nouwens A, Hendrikx I, Fry BG (2014) Fossilized venom: the unusually conserved venom profiles of Heloderma species (beaded lizards and gila monsters). Toxins 6:3582–3595CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Sanggaard KW, Dyrlund TF, Thomsen LR, Nielsen TA, Brøndum L, Wang T, Thøgersen IB, Enghild JJ (2015) Characterization of the gila monster (Heloderma suspectum suspectum) venom proteome. J Proteom 117:1–11CrossRef Sanggaard KW, Dyrlund TF, Thomsen LR, Nielsen TA, Brøndum L, Wang T, Thøgersen IB, Enghild JJ (2015) Characterization of the gila monster (Heloderma suspectum suspectum) venom proteome. J Proteom 117:1–11CrossRef
7.
Zurück zum Zitat Alagon A, Possani LD, Smart J, Schleuning WD (1986) Helodermatine, a kallikrein-like, hypotensive enzyme from the venom of Heloderma horridum horridum (Mexican beaded lizard). J Exp Med 164:1835–1845CrossRefPubMed Alagon A, Possani LD, Smart J, Schleuning WD (1986) Helodermatine, a kallikrein-like, hypotensive enzyme from the venom of Heloderma horridum horridum (Mexican beaded lizard). J Exp Med 164:1835–1845CrossRefPubMed
8.
Zurück zum Zitat Sosa BP, Alagón AC, Martin BM, Possani LD (1986) Biochemical characterization of the phospholipase A2 purified from the venom of the Mexican beaded lizard (Heloderma horridum horridum Wiegmann). Biochemistry 25:2927–2933CrossRefPubMed Sosa BP, Alagón AC, Martin BM, Possani LD (1986) Biochemical characterization of the phospholipase A2 purified from the venom of the Mexican beaded lizard (Heloderma horridum horridum Wiegmann). Biochemistry 25:2927–2933CrossRefPubMed
9.
Zurück zum Zitat Datta G, Tu AT (1997) Structure and other chemical characterizations of gila toxin, a lethal toxin from lizard venom. J Pept Res 50:443–450CrossRefPubMed Datta G, Tu AT (1997) Structure and other chemical characterizations of gila toxin, a lethal toxin from lizard venom. J Pept Res 50:443–450CrossRefPubMed
10.
Zurück zum Zitat Ivanov I, Matafonov A, Sun MF, Cheng Q, Dickeson SK, Verhamme M, Emsley J, Gailani D (2017) Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation. Blood 129:1527–1537CrossRefPubMedPubMedCentral Ivanov I, Matafonov A, Sun MF, Cheng Q, Dickeson SK, Verhamme M, Emsley J, Gailani D (2017) Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation. Blood 129:1527–1537CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Mohammed BM, Matafonov A, Ivanov I, Sun MF, Cheng Q, Dickeson SK, Li C, Sun D, Verhamme IM, Emsley J, Gailani D (2018) An update on factor XI structure and function. Thromb Res 161:94–105CrossRefPubMed Mohammed BM, Matafonov A, Ivanov I, Sun MF, Cheng Q, Dickeson SK, Li C, Sun D, Verhamme IM, Emsley J, Gailani D (2018) An update on factor XI structure and function. Thromb Res 161:94–105CrossRefPubMed
12.
Zurück zum Zitat Nielsen VG, Cohen BM, Cohen E (2005) Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 49:222–231CrossRefPubMed Nielsen VG, Cohen BM, Cohen E (2005) Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 49:222–231CrossRefPubMed
13.
Zurück zum Zitat Nielsen VG (2019) Carbon monoxide inhibits the anticoagulant activity of phospholipase A2 purified from Crotalus adamanteus venom. J Thromb Thrombolysis 47:73–79CrossRefPubMed Nielsen VG (2019) Carbon monoxide inhibits the anticoagulant activity of phospholipase A2 purified from Crotalus adamanteus venom. J Thromb Thrombolysis 47:73–79CrossRefPubMed
14.
Zurück zum Zitat Nielsen VG, Cerruti MA, Valencia OM, Amos Q (2016) Decreased snake venom metalloproteinase effects via inhibition of enzyme and modification of fibrinogen. Biometals 29:913–919CrossRefPubMed Nielsen VG, Cerruti MA, Valencia OM, Amos Q (2016) Decreased snake venom metalloproteinase effects via inhibition of enzyme and modification of fibrinogen. Biometals 29:913–919CrossRefPubMed
15.
Zurück zum Zitat Nielsen VG, Frank N (2019) Role of heme modulation in inhibition of Atheris, Atractaspis, Causus, Cerastes, Echis, and Macrovipera hemotoxic venom activity. Hum Exp Toxicol 38:216–226CrossRefPubMed Nielsen VG, Frank N (2019) Role of heme modulation in inhibition of Atheris, Atractaspis, Causus, Cerastes, Echis, and Macrovipera hemotoxic venom activity. Hum Exp Toxicol 38:216–226CrossRefPubMed
16.
Zurück zum Zitat Nielsen VG, Frank N, Matika RW (2018) Carbon monoxide inhibits hemotoxic activity of Elapidae venoms: potential role of heme. Biometals 31:51–59CrossRefPubMed Nielsen VG, Frank N, Matika RW (2018) Carbon monoxide inhibits hemotoxic activity of Elapidae venoms: potential role of heme. Biometals 31:51–59CrossRefPubMed
17.
Zurück zum Zitat Nielsen VG, Bazzell CM (2016) Carbon monoxide attenuates the effects of snake venoms containing metalloproteinases with fibrinogenase or thrombin-like activity on plasmatic coagulation. MedChemComm 7:1973–1979CrossRef Nielsen VG, Bazzell CM (2016) Carbon monoxide attenuates the effects of snake venoms containing metalloproteinases with fibrinogenase or thrombin-like activity on plasmatic coagulation. MedChemComm 7:1973–1979CrossRef
18.
Zurück zum Zitat Nielsen VG, Bazzell CM (2017) Carbon monoxide releasing molecule-2 inhibition of snake venom thrombin-like activity: novel biochemical “brake”? J Thromb Thrombolysis 43:203–208CrossRefPubMed Nielsen VG, Bazzell CM (2017) Carbon monoxide releasing molecule-2 inhibition of snake venom thrombin-like activity: novel biochemical “brake”? J Thromb Thrombolysis 43:203–208CrossRefPubMed
19.
Zurück zum Zitat Nielsen VG, Frank N (2018) Differential heme-mediated modulation of Deinagkistrodon, Dispholidus, Protobothrops and Pseudonaja hemotoxic venom activity in human plasma. Biometals 31:951–959CrossRefPubMed Nielsen VG, Frank N (2018) Differential heme-mediated modulation of Deinagkistrodon, Dispholidus, Protobothrops and Pseudonaja hemotoxic venom activity in human plasma. Biometals 31:951–959CrossRefPubMed
20.
Zurück zum Zitat Nielsen VG, Frank N, Matika RW (2018) Effects of heme modulation on Ovophis and Trimeresurus venom activity in human plasma. Toxins (Basel) 10:E322CrossRef Nielsen VG, Frank N, Matika RW (2018) Effects of heme modulation on Ovophis and Trimeresurus venom activity in human plasma. Toxins (Basel) 10:E322CrossRef
21.
Zurück zum Zitat Nielsen VG, Losada PA (2017) Direct inhibitory effects of carbon monoxide on six venoms containing fibrinogenolytic metalloproteinases. Basic Clin Pharmacol Toxicol 120:207–212CrossRefPubMed Nielsen VG, Losada PA (2017) Direct inhibitory effects of carbon monoxide on six venoms containing fibrinogenolytic metalloproteinases. Basic Clin Pharmacol Toxicol 120:207–212CrossRefPubMed
22.
Zurück zum Zitat Suntravat M, Langlais PR, Sánchez EE, Nielsen VG (2018) CatroxMP-II: a heme-modulated fibrinogenolytic metalloproteinase isolated from Crotalus atrox venom. Biometals 31:585–593CrossRefPubMedPubMedCentral Suntravat M, Langlais PR, Sánchez EE, Nielsen VG (2018) CatroxMP-II: a heme-modulated fibrinogenolytic metalloproteinase isolated from Crotalus atrox venom. Biometals 31:585–593CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Nielsen VG (2018) Crotalus atrox venom exposed to carbon monoxide has decreased fibrinogenolytic activity in vivo in rabbits. Basic Clin Pharmacol Toxicol 122:82–86CrossRefPubMed Nielsen VG (2018) Crotalus atrox venom exposed to carbon monoxide has decreased fibrinogenolytic activity in vivo in rabbits. Basic Clin Pharmacol Toxicol 122:82–86CrossRefPubMed
24.
Zurück zum Zitat Murakami M, Taketomi Y, Sato H, Yamamoto K (2011) Secreted phospholipase A2 revisited. J Biochem 150:233–255CrossRef Murakami M, Taketomi Y, Sato H, Yamamoto K (2011) Secreted phospholipase A2 revisited. J Biochem 150:233–255CrossRef
25.
Zurück zum Zitat Koludarov I, Jackson TN, Brouw BOD, Dobson J, Dashevsky D, Arbuckle K, Clemente CJ, Stockdale EJ, Cochran C, Debono J, Stephens C, Panagides N, Li B, Manchadi MR, Violette A, Fourmy R, Hendrikx I, Nouwens A, Clements J, Martelli P, Kwok HF, Fry BG (2017) Enter the dragon: the dynamic and multifunctional evolution of Anguimorpha lizard venoms. Toxins (Basel) 9:E242CrossRef Koludarov I, Jackson TN, Brouw BOD, Dobson J, Dashevsky D, Arbuckle K, Clemente CJ, Stockdale EJ, Cochran C, Debono J, Stephens C, Panagides N, Li B, Manchadi MR, Violette A, Fourmy R, Hendrikx I, Nouwens A, Clements J, Martelli P, Kwok HF, Fry BG (2017) Enter the dragon: the dynamic and multifunctional evolution of Anguimorpha lizard venoms. Toxins (Basel) 9:E242CrossRef
Metadaten
Titel
The kallikrein-like activity of Heloderma venom is inhibited by carbon monoxide
verfasst von
Vance G. Nielsen
Nathaniel Frank
Publikationsdatum
06.04.2019
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 4/2019
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-019-01853-6

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Koronare Herzkrankheit: Das waren die Top-Studien in 2024

Zum Thema Koronare Herzkrankheit gab es 2024 wichtige neue Studien. Beleuchtet wurden darin unter anderem der Stellenwert von Betablockern nach Herzinfarkt, neue Optionen für eine Lipidsenkung sowie die Therapie bei infarktbedingtem kardiogenem Schock.

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Inhalative Steroide bei COPD nicht kardioprotektiv

  • 10.01.2025
  • COPD
  • Nachrichten

Ob inhalative Kortikosteroide (ICS) COPD-Kranke außer vor akuten Exazerbationen auch vor kardiovaskulären Komplikationen schützen können, ist unklar. Eine bevölkerungsbasierte Studie aus England spricht nicht dafür.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.